Evaluation of the Survival and Safety of Biologic and Targeted Synthetic DMARD in Patients with Difficult-to-Treat RA Using Real-World Data from a Nationwide Registry of Rheumatic Diseases
02/12/2024
Adrián Quevedo-Rodríguez, Lucia Otero-Varela, Fernando Sánchez-Alonso, Yanira Pérez-Vera, Javier Manero-Ruiz, Cristina Campos-Fernández, Sara Manrique-Arija, Paloma Vela-Casasempere, Antonio Mera-Varela, César Díaz, Atusa Movasat, Blanca Garcia-Magallon, Inmaculada Ros-Vilamajó, Carolina Perez-Garcia and Isabel Castrejon, and BIOBADASER working group.
ACR 2024
https://acrabstracts.org/abstract/evaluation-of-the-survival-and-safety-of-biologic-and-targeted-synthetic-dmard-in-patients-with-difficult-to-treat-ra-using-real-world-data-from-a-nationwide-registry-of-rheumatic-diseases/